abstract |
The invention relates to the use of angiotensin II receptor antagonists for the treatment of individuals diagnosed with or suspected of having diabetes mellitus type 2, for the prevention of diabetes or for the treatment of metabolic syndrome and insulin resistance in patients with normal blood pressure. |